BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 9423301)

  • 1. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCG vaccination in India and tuberculosis in children: newer facets.
    Udani PM
    Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis control strategy in the 21st century in Japan--for elimination of tuberculosis in Japan].
    Aoki M
    Kekkaku; 2001 Jul; 76(7):549-57. PubMed ID: 11517563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
    Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
    Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG vaccine: efficacy and indications for vaccination and revaccination.
    Barreto ML; Pereira SM; Ferreira AA
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S45-54. PubMed ID: 16826312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in tuberculosis vaccines.
    Haile M; Källenius G
    Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The present and future of tuberculosis vaccinations.
    Principi N; Esposito S
    Tuberculosis (Edinb); 2015 Jan; 95(1):6-13. PubMed ID: 25458613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.